Kyverna Therapeutics, Inc. ( KYTX) - Stock Earnings
KYTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -37.8 million USD | — USD |
| 2026Q1 | -39.7 million USD | — USD |
| 2026Q2 | -38.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
KYTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -60.4 million USD | — USD |
| 2024 | -127.5 million USD | — USD |
| 2025 | -161.3 million USD | — USD |
| 2026 Est. | — | — |
KYTX
Price: $8.13
52 week price:
Earnings Per Share: -3.21 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 553.5 million